Pharmacodynamic Differences Between Branded and Unbranded Remifentanil Molecules
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Unbranded drug molecules are produced after the patent of a given drug has expired. Unbranded
molecules of Remifentanil have been marketed in Colombia, and several reports by
anesthesiologist indicate that there are differences in the physiologic response of patients
to these molecules. The investigators hypothesized that unbranded molecules of remifentanil
require higher doses to obtain desired physiological responses as compared to the branded
molecule.